Beyond promoting their effects on sustained tumour growth, it has become clear that both the PI3K and ERK/MAPK axis mediate acquired resistance to broad categories of anti-cancer agents.93 The first evidence that RTK signalling may be involved in both intrinsic and acquired resistance to BETi came from unexpected observations in sensitive cells. Here, PIK3CA is linked to cancer.